Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.
Where this comes from
- Record sourced from PubMed, PMID 12032329.
- Also identified by PMC identifier 124296.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Benign prostatic hyperplasia (BPH) is a disease of unknown etiology that significantly affects the quality of life in aging men. Histologic BPH may present itself either as symptomatic or asymptomatic in nature. To elucidate the molecular differences underlying BPH, gene expression profiles from the prostate transition zone tissue have been analyzed by using microarrays. A set of 511 differentially expressed genes distinguished symptomatic and asymptomatic BPH. This genetic signature separates BPH from normal tissue but does not seem to change with age. These data could provide novel approaches for alleviating symptoms and hyperplasia in BPH.
Medical subject headings
- Oligonucleotide Array Sequence Analysis
- Prostatic Hyperplasia